Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART versus fixed-dose Symbicort plus terbutaline in asthma
2008-006869-86Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide and terbutaline in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Time to first asthma exacerbation. Started Dec 2008; status: completed.
02
Drugs
budesonideterbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-006869-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006869-86.